Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients.
about
Contralateral prophylactic mastectomy rate stable at major Canadian breast cancer centerContralateral prophylactic mastectomy: current perspectivesDecision-Making in the Surgical Treatment of Breast Cancer: Factors Influencing Women's Choices for Mastectomy and Breast Conserving SurgeryUnique features of young age breast cancer and its managementRisk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes researchImpact of availability of immediate breast reconstruction on bilateral mastectomy rates for breast cancer across the United States: data from the nationwide inpatient sample.Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.Disparities in contralateral prophylactic mastectomy use among women with early-stage breast cancer.Breast cancer in young women: special considerations in multidisciplinary care.Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011.Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations.Breast cancer in young womenContralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies.Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysisCurrent knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer.Role of preoperative magnetic resonance imaging in the surgical management of early-stage breast cancerCo-modulation analysis of gene regulation in breast cancer reveals complex interplay between ESR1 and ERBB2 genesImpact of reconstruction and reoperation on long-term patient-reported satisfaction after contralateral prophylactic mastectomy.Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias.HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ.Mastectomy and contralateral prophylactic mastectomy rates: an institutional review.Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status.SEOM clinical guidelines in early-stage breast cancer 2015Bilateral Mastectomy for Unilateral Breast Cancer: a Perplexing TrendContralateral Prophylactic Mastectomy: Challenging Considerations for the SurgeonIntentions for bilateral mastectomy among newly diagnosed breast cancer patientsApplication of immediate breast reconstruction with silicon prosthetic implantation following bilateral mammary gland excision in treatment of young patients with early breast cancer.Immediate reconstruction following nipple-sparing mastectomy: one option for young breast cancer patients with early stage diseaseEstablishing a program for individuals at high risk for breast cancer.Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research.Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer.Decision making for breast cancer prevention among women at elevated riskSelecting local therapy in the young breast cancer patient.Bilateral breast cancers.Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.Prophylactic mastectomy: who needs it, when and why.State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012.Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
P2860
Q24658472-75364EC7-9959-44DD-8C91-A4E62A567C8EQ26744320-CBC9F609-BFF6-4FAF-9A70-82E2CF147346Q26749389-521753E6-1CBE-486B-ACB0-828249AB9B0BQ26821902-373C764C-2BA6-4CD0-AF9C-116DD2DB1F59Q30415050-775DB109-427F-40C1-8C87-743B9193B683Q30671803-5E42798B-39DA-4F5C-BD74-722AB3565449Q30838002-1A52BA60-B319-4261-86AC-F0AC0B7DB4A9Q31118195-09FEC97C-5B3C-47DC-B353-D35B7ADAA9D8Q33767098-E9088CF7-47C0-4089-8F43-FB1D9E593199Q34306522-EE6E5AE9-E870-4495-B64F-8F443D5B0C23Q34436508-CB6EE953-7657-4DB3-9DC8-CA953B93E4E0Q34629071-D83C10DE-0D4E-4797-8F7E-5772013EC637Q34989073-EC5BD461-5E88-4CEA-B3B9-4017FAF10CD0Q35066801-D728D8C4-606B-43C0-AF7C-2D8324A2F3BDQ35192288-251DC3B6-2747-48C0-9039-6058A7D7B2E0Q35584662-48351328-2FC7-4763-9B52-6ADD7FB6A3EBQ35634061-BAC4D7CB-C6D4-4019-9604-658C83B81C39Q35671323-0FB7D8FB-C187-4991-9318-DCBDA47A915FQ35838312-09196D5A-4DB2-40A0-8E5E-F361F86B9106Q35850183-4991F45E-C9D6-4330-B577-94D37413CF1CQ35899068-4E665076-FFD8-40E7-BCE1-A44FD43800B0Q36026667-11C3166B-3CFA-40B8-A26E-3242FC03473BQ36339415-76FC202F-54E4-4305-B031-2456D5AE8CBDQ36400320-2CAF4145-0D7A-4444-BAC6-10F36F7E4A7BQ36734744-79D23223-81A1-4410-B92B-4BD81A869B5BQ36812287-044C35BE-FEB0-43E0-9F50-E339F3AF2D05Q36943042-8C85BF2C-F417-4CC9-8BA0-D6E022A39CFAQ36972952-DD03BE8C-C285-43B2-AAEB-D8DAE8FB94E3Q36973006-9871FD0C-7C06-4737-9D02-4A410BD10CA7Q36983389-D223D629-77C5-4BFC-8A51-18490204A505Q37151892-AE832069-D63D-4C7A-81DC-0961AAAD5CF5Q37387444-76FAF663-EFE5-48E5-B138-BCB1E381B8E3Q37661126-442C121A-8CE2-429C-BC1E-C348A31E03EFQ37720955-665BA081-4A32-4583-A9EF-DCF7D6B23F30Q37845314-7E381558-CB7B-4AA1-93EA-D718D3B88523Q38184906-4E144257-DC3E-4E91-B148-D0500E111878Q38206470-4FCB8638-6B2E-49A6-A2DD-C3C06D3775E6Q38223259-D11F1156-0391-4621-BC04-E299587D56FCQ38738100-97FDE23B-1DC3-439B-AF28-438CD7303EC0Q38846562-762412CC-8FF9-4CE2-8491-B4C2A6FB18D0
P2860
Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Population-based study of cont ...... mes of breast cancer patients.
@ast
Population-based study of cont ...... mes of breast cancer patients.
@en
type
label
Population-based study of cont ...... mes of breast cancer patients.
@ast
Population-based study of cont ...... mes of breast cancer patients.
@en
prefLabel
Population-based study of cont ...... mes of breast cancer patients.
@ast
Population-based study of cont ...... mes of breast cancer patients.
@en
P2093
P2860
P356
P1476
Population-based study of cont ...... mes of breast cancer patients.
@en
P2093
Chung-Yuan Hu
George J Chang
Isabelle Bedrosian
P2860
P304
P356
10.1093/JNCI/DJQ018
P407
P577
2010-02-25T00:00:00Z